SKETCHES OF COURT: First witness in Shkreli trial reported too-good-to-be-true returns
An investor in “Pharma Bro” Martin Shkreli’s hedge fund says he wowed her by reporting eye-popping returns that prosecutors say were a lie.
Sarah Hassan testified Thursday as the first witness at Shkreli’s security fraud trial in Brooklyn federal court.
She told jurors she invested $300,000 with Shkreli in 2011 after being told he was “a rising star in the hedge fund world” who managed $40 million. She said she was thrilled when he reported she made nearly $60,000 that year alone.